"It appears that the defendant has kept the pack of the plaintiff in front while preparing its pack," the court said.

Roche's bid to block a generic SMA drug risks public health by limiting affordable access, say patient groups, highlighting high costs and patent issues.

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug ...

The company, which processes food waste into animal feed, is facing a lawsuit from the attorney general's office.

Lyft Inc. has agreed to pay $2.1 million in civil penalties to resolve allegations of making false and misleading statements ...

Clear geographic boundaries in a statutory injunction gave police much-needed power to enforce bylaws during Freedom Convey ...

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue ...